Europe Set to Approve Moderna, Pfizer Omicron-Tailored Shots
- EU advisory panel to discuss vaccines at Thursday meeting
- Continent wants to sharpen its response to an evolving virus
This article is for subscribers only.
Europe’s drug regulator is set to recommend omicron-tailored vaccines from the Pfizer Inc.-BioNTech SE partnership and Moderna Inc. Thursday ahead of a fall rollout of booster shots across the continent.
An advisory panel of the European Medicines Agency will meet Thursday to consider the two bivalent mRNA booster vaccines, which target the original version of the coronavirus as well as BA.1, an early strain of the omicron variant that fueled new Covid-19 infections last winter.